I-mab Share Price (NASDAQ: IMAB)

$4.16

▲

-0.09

(-2.12%)

Last updated on August 30, 2025 at 1:29 am IST

$₹

Check the interactive I-mab Stock chart to analyse performance

I-mab stock performance

as on August 30, 2025 at 1:29 am IST

Today's Low:$3.98
Today's High:$4.33
$4.16
4.33%
Downside
Day's Volatility :8.08%
Upside
3.93%
52 Weeks Low:$0.60
52 Weeks High:$5.90
$4.16
85.7%
Downside
52 Weeks Volatility :89.92%
Upside
29.49%

I-mab Stock Returns

Period	I-mab	Sector (Health Care)	Index (Russel 2000)
3 Months	225.78%	3.6%	0.0%
6 Months	351.25%	-7.7%	0.0%
1 Year	297.14%	-12.6%	0.0%
3 Years	-33.7%	10.2%	-4.1%

I-mab Key Stats

Check I-mab key stats like market cap, P/E ratio, EPS, Dividend Yield, and more.

Previous Close	$4.25
Open	$4.36
Today's High	$4.33
Today's Low	$3.98
Market Capitalization	$347.1M
Today's Volume	$1.4M
52 Week High	$5.9
52 Week Low	$0.595
Revenue TTM	$3.5M
EBITDA	$-38.0M
Earnings Per Share (EPS)	$-0.51
Profit Margin	0.0%
Quarterly Earnings Growth YOY	0.0%
Return On Equity TTM	-17.08%

Stock Returns calculator for I-mab Stock including INR - Dollar returns

The I-mab stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.

Investment Value

₹1,00,000

I-mab investment value today

Current value as on today

₹4,01,475

Returns

₹3,01,475

(+301.47%)

Returns from I-mab Stock

₹2,96,190 (+296.19%)

Dollar Returns*

₹5,284 (+5.28%)

Indian investors sentiment towards I-mab Stock

639.13%

Period: Jul 31, 2025 to Aug 30, 2025. Change in 30 Days versus previous period

Investment in I-mab Shares from India has grown by 639.13% over the past 30 days, indicating increased transactional activity.

1433%

Period: Jul 31, 2025 to Aug 30, 2025. Change in 30 Days versus previous period

Search interest for I-mab Stock from India on INDmoney has increased by 1433% in the last 30 days, reflecting an upward trend in search activity.

Global Institutional Holdings in I-mab

Name
Holdings %
Name
Holdings %
Hillhouse Capital Advisors, Ltd.
7.31%
SG Americas Securities, LLC
1.01%
UBS Group AG
0.39%
Two Sigma Advisers, LLC
0.26%
Aberdeen Group PLC
0.17%
BNP Paribas Arbitrage, SA
0.15%

Analyst Recommendation on I-mab Stock

Rating

Trend

Buy

90%Buy

9%Hold

0%Sell

Based on 11 Wall street analysts offering stock ratings for I-mab(by analysts ranked 0 to 5 stars)

I-mab Share Price Target

What analysts predicted

Upside of 58.65%

Target:

$6.60

Current:

$4.16

I-mab share price target is $6.60, a slight Upside of 58.65% compared to current price of $4.16 as per analysts' prediction.

I-mab Stock Insights

Price Movement
In the last 1 month, IMAB stock has moved up by 107.5%
Increasing Revenue
Revenue is up for the last 2 quarters, 3.27M → 3.99M (in $), with an average increase of 18.1% per quarter
Decreasing Net Profit
Netprofit is down for the last 2 quarters, -3.15M → -5.50M (in $), with an average decrease of 74.7% per quarter
IMAB vs ALNY (3 yr)
In the last 3 years, Alnylam Pharmaceuticals, Inc. has given 116.0% return, outperforming this stock by 148.0%

I-mab Technicals Summary

Sell

Neutral

Buy

I-mab is currently in a neutral trading position according to technical analysis indicators.

I-mab Vs Peers

Returns

Ratio's

Overview

Company Name	1 Month	6 Month	1 Year	3 Years	5 Years
I-mab	59.16%	351.25%	297.14%	-33.7%	-94.79%
Regeneron Pharmaceuticals, Inc.	3.92%	-15.2%	-50.31%	-3.3%	-2.01%
Beone Medicines Ltd	2.49%	24.81%	62.78%	79.11%	29.69%
Vertex Pharmaceuticals Incorporated	-15.42%	-19.13%	-17.84%	34.68%	41.87%
Alnylam Pharmaceuticals, Inc.	11.08%	83.28%	75.87%	111.28%	242.25%

Company Name	P/E Ratio	P/B Ratio	PEG Ratio	EPS	ROE	ROA	Div Yield	BVPS
I-mab	NA	NA	NA	-0.34	-0.17	-0.1	NA	2.4
Regeneron Pharmaceuticals, Inc.	14.6	14.6	1.2	39.42	0.15	0.07	0.0	287.55
Beone Medicines Ltd	NA	NA	NA	2.73	-0.05	-0.01	NA	34.32
Vertex Pharmaceuticals Incorporated	27.86	27.86	0.58	18.06	0.23	0.13	NA	67.02
Alnylam Pharmaceuticals, Inc.	NA	NA	-0.49	3.92	-2.58	-0.03	NA	1.91

Company Name	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin
I-mab	Buy	$347.1M	-94.79%	NA	0.0%
Regeneron Pharmaceuticals, Inc.	Buy	$61.4B	-2.01%	14.6	31.37%
Beone Medicines Ltd	NA	$36.5B	29.69%	NA	-3.89%
Vertex Pharmaceuticals Incorporated	Buy	$100.5B	41.87%	27.86	31.86%
Alnylam Pharmaceuticals, Inc.	Buy	$59.5B	242.25%	NA	-12.96%

About I-mab

I-Mab, a biotech company, focuses on the development of immuno-oncology agents for the treatment of cancer in the United States. The company is developing givastomig, a bispecific antibody, which is in Phase 1b clinical trial for the treatment of gastric cancer; uliledlimab, a CD73 neutralizing antibody; and ragistomig, a bispecific antibody, which is in phase 1 clinical trial for the treatment of solid tumors. It has a strategic licensing agreement with Ferring International Center SA to research, develop, make, have made, import, use, sell, and offer to sell FE301, an interleukin-6 inhibitor. The company also has collaborations with Bristol Myers Squibb for the development of givastomig; ABL Bio, Inc. for the development of givastomig and ragistomig; and TJ Bio for the development of uliledlimab. I-Mab was founded in 2014 and is headquartered in Rockville, Maryland.

Organization	I-mab
Employees	32
CEO	Dr. Xi-Yong Fu M.B.A., Ph.D.
Industry	Health Technology

Key Management of I-mab

Name	Title
Dr. Xi-Yong Fu M.B.A., Ph.D.	CEO & Director
Mr. Skelton Joseph	Chief Financial Officer
Mr. Tyler Ehler	Senior Director of Investor Relations
Dr. Claire Xu M.D., Ph.D.	Senior Vice President of Clinical Development
Dr. Phillip Dennis M.D., Ph.D.	Chief Medical Officer

Important FAQs about investing in IMAB Stock from India :

What is I-mab share price today?

I-mab share price today is $4.16 as on August 30, 2025 at 1:29 am IST at the close of the market. I-mab share today touched a day high of $4.33 and a low of $3.98.

What is the 52 week high and 52 week low for I-mab share?

I-mab share touched a 52 week high of $5.90 and a 52 week low of $0.60. I-mab stock price today i.e. August 30, 2025 at 1:29 am IST is closed at $4.16, lower by 29.49% versus the 52 week high.

How to invest in I-mab Stock (IMAB) from India?

Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
Step 2: Search for I-mab on INDmoney app. Click on Buy button. You can invest as low as $1.5 in I-mab Shares that will get you 0.3606 shares as per I-mab share price of $4.16 per share as on August 30, 2025 at 1:29 am IST.

What is the minimum amount required to buy I-mab Stock (IMAB) from India?

Indian investors can start investing in I-mab (IMAB) shares with as little as ₹88.286 or $1 (as of August 31, 2025) using the INDmoney app.
For example: If you want to invest $10 or ₹882.86 in I-mab stock (as per the Rupee-Dollar exchange rate as on August 31, 2025). Based on I-mab share’s latest price of $4.16 as on August 30, 2025 at 1:29 am IST, you will get 2.4038 shares of I-mab. Learn more about fractional shares .

What are the returns that I-mab has given to Indian investors in the last 5 years?

I-mab stock has given -94.79% share price returns and 20.51% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?